Developing the DeepNovo Platform to Determine the Most Immunogenic Peptides to Create an Immune Response to Personalized Cancer Vaccines
Time: 12:30 pm
day: Conference Day One
Details:
- Finding novo sequences by de novo mass spectrometry sequencing to determine better neoantigen targets
- Employing AI in proteomics to discover peptides with immunogenicity for more effective cancer vaccines
- Confirming the power of bioinformatics in neoantigen detection and validation by experimental methods for best patient response to individualized cancer vaccines
